Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to Fuel Tumor Progression - Source data file

Source data file linked to manuscript “Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to Fuel Tumor Progression” Authors: Carolina F. Ruivo1,2,3*, Nuno Bastos1,2,3*, Bárbara Adem1,2,3, Inês A. Batista1,2,3, Cecília Duraes1,2, Carlos A. Melo4, Stéphanie A. Castaldo1,2,5, Francisco J Campos‐Laborie4, Pedro Moutinho-Ribeiro6,7, Barbara Mourão8, Ana R. Costa-Pinto1,2, Soraia da Silva1,2¥, Hugo Osorio1,2,7, Sergio Ciordia9, José L. Costa2,7, David W. Goodrich10, Bruno Cavadas1,2, Luisa Pereira1,2, Tony Kouzarides4, Guilherme Macedo6,7, Rui Maio8,11, Fátima Carneiro1,2,12,Marília Cravo11, Raghu Kalluri13, José C. Machado1,2,7, Sonia A. Melo1,2,7# 1. i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.2. Institute of Molecular Pathology and Immunology of University of Porto, Ipatimup, 4200-135 Porto, Portugal.3. Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.4. The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, United Kingdom.5. VIB Center for Cancer Biology and KU Leuven Department of Oncology, University of Leuven, Belgium.6. Gastroenterology Department, Centro Hospitalar e Universitário São João, Porto, Portugal.7. Faculty of Medicine, University of Porto, Porto, Portugal.8. Gastroenterology Department, Hospital Beatriz Ângelo, 2674-514 Lisboa, Portugal.9. Proteomics Facility, Spanish National Center for Biotechnology (CNB-CSIC), 28049 Madrid, Spain.10. Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263.11. Hospital da Luz, 1500-650 Lisboa, Portugal.12. Department of Pathology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.13. Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. *These authors contributed equally to this work.